Search

everythinglearnresearchcommunity

for

Search:↓

Zinc supplements may be needed to treat hair loss in hypothyroidism.

A hair-straightening product caused widespread hair loss and scalp injuries, mainly affecting African American women.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Trichoscopy can effectively tell apart tinea capitis and alopecia areata in children by looking for specific hair shapes.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Corticosteroids may effectively regrow hair in Alopecia Totalis with manageable side effects.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Niacin derivatives may increase hair fullness in women with hair loss.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.